Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Current Liabilities ₹365 Cr₹262 Cr₹216 Cr₹194 Cr₹98 Cr

What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹365 Cr
Mar2024₹262 Cr
Mar2023₹216 Cr
Mar2022₹194 Cr
Mar2013₹98 Cr

How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹365 Cr
39.19
Mar2024 ₹262 Cr
21.26
Mar2023 ₹216 Cr
11.40
Mar2022 ₹194 Cr
98.02
Mar2013 ₹98 Cr -

Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹327.2 Cr 19.3% 16% -5.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,134.7 Cr 1.4% -7% -15.8% Stock Analytics
KAVERI SEED COMPANY ₹4,768.7 Cr 6.9% 14.9% -36.5% Stock Analytics
VENKYS (INDIA) ₹2,083.2 Cr 8.1% 13.8% -10.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,061.8 Cr -9.8% 20.4% -20.4% Stock Analytics
INDO US BIOTECH ₹213.8 Cr 2.3% 6% -33.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

19.3%

16%

-5.8%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses